Primary Site >> Liver Cancer
Gene >> IGFBP3
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma. PMID: 10601571 |
Ref: Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study. PMID: 14642619 |
Ref: Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation. PMID: 15661074 |
Ref: Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma. PMID: 17006947 Ref: A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. PMID: 17087938 |
Ref: Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. PMID: 17717605 |
Ref: Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. PMID: 19070387 |
Ref: IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. PMID: 20206398 |
Ref: Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy. PMID: 22623732 |
Ref: The insulin-like growth factor-1 and expression of its binding protein3 in chronic hepatitis C and hepatocellular carcinoma. PMID: 23784592 Ref: SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. PMID: 23878061 |
Ref: Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis. PMID: 29113370 |
Ref: Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma. PMID: 29507645 |